Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early-Treated Infants With HIV.
Puthanakit T, Ananworanich J, Akapirat S, Pattanachaiwit S, Ubolyam S, Assawadarachai V, Sawangsinth P, Jupimai T, Anugulruengkitt S, Tawan M, Kosalaraksa P, Borkird T, Suntarattiwong P, Kanjanavanit S, de Souza MS; RV475/HIV-NAT209 Study Group. Puthanakit T, et al. Among authors: tawan m. J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):260-266. doi: 10.1097/QAI.0000000000002254. J Acquir Immune Defic Syndr. 2020. PMID: 31917751 Free PMC article.
Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N, Anugulruengkitt S, Rattananupong T, Prinyawat M, Jantarabenjakul W, Wacharachaisurapol N, Chatsuwan T, Janewongwirot P, Suchartlikitwong P, Tawan M, Kanchanabutr P, Pancharoen C, Puthanakit T. Jitrungruengnij N, et al. Among authors: tawan m. Pediatr Int. 2020 Jul;62(7):789-796. doi: 10.1111/ped.14200. Epub 2020 Jul 9. Pediatr Int. 2020. PMID: 32065485 Clinical Trial.
Pharmacokinetics and Safety of WHO-Recommended Dosage and Higher Dosage of Levofloxacin for Tuberculosis Treatment in Children: a Pilot Study.
Jantarabenjakul W, Suntarattiwong P, Wacharachaisurapol N, Supradish Na Ayudhya P, Phaisal W, Tawan M, Moonwong J, Sudjaritruk T, Chariyavilaskul P, Puthanakit T. Jantarabenjakul W, et al. Among authors: tawan m. Int J Infect Dis. 2022 Sep;122:603-608. doi: 10.1016/j.ijid.2022.07.029. Epub 2022 Jul 13. Int J Infect Dis. 2022. PMID: 35842213 Free article.
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.
Chantasrisawad N, Puthanakit T, Kornsitthikul K, Jaru-Ampornpan P, Tawan M, Matapituk P, Sophonphan J, Anugulruengkitt S, Tangsathapornpong A, Katanyutanon A; KIDSBOOST study team*. Chantasrisawad N, et al. Among authors: tawan m. Vaccine X. 2022 Sep 30;12:100221. doi: 10.1016/j.jvacx.2022.100221. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36213592 Free PMC article.
Temporal trend of drug-resistant tuberculosis among Thai children during 2006-2021.
Jantarabenjakul W, Supradish Na Ayudhya P, Suntarattiwong P, Thepnarong N, Rotcheewaphan S, Udomsantisuk N, Moonwong J, Kosulvit P, Tawan M, Sudjaritruk T, Puthanakit T. Jantarabenjakul W, et al. Among authors: tawan m. IJID Reg. 2022 Sep 18;5:79-85. doi: 10.1016/j.ijregi.2022.09.005. eCollection 2022 Dec. IJID Reg. 2022. PMID: 36238580 Free PMC article.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Puthanakit T, Chokephaibulkit K, Chaithongwongwatthana S, Bhat N, Tang Y, Anugulruengkitt S, Chayachinda C, Anuwutnavin S, Lapphra K, Rungmaitree S, Tawan M, Andi-Lolo I, Holt R, Fortuna L, Kerdsomboon C, Yuwaree V, Mansouri S, Thai PH, Innis BL. Puthanakit T, et al. Among authors: tawan m. Vaccine. 2023 Jul 12;41(31):4541-4553. doi: 10.1016/j.vaccine.2023.06.001. Epub 2023 Jun 15. Vaccine. 2023. PMID: 37330371 Free PMC article. Clinical Trial.
Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance.
Nantanee R, Jaru-Ampornpan P, Chantasrisawad N, Himananto O, Papakhee S, Sophonphan J, Tawan M, Jupimai T, Anugulruengkitt S, Puthanakit T; Study Team. Nantanee R, et al. Among authors: tawan m. Vaccine X. 2023 Aug 5;15:100367. doi: 10.1016/j.jvacx.2023.100367. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37601322 Free PMC article.
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Chokephaibulkit K, Puthanakit T, Chaithongwongwatthana S, Bhat N, Tang Y, Anugulruengkitt S, Chayachinda C, Anuwutnavin S, Lapphra K, Rungmaitree S, Tawan M, Andi-Lolo I, Holt R, Fortuna L, Kerdsomboon C, Yuwaree V, Mansouri S, Thai PH, Innis BL. Chokephaibulkit K, et al. Among authors: tawan m. Vaccine. 2024 Jan 12;42(2):383-395. doi: 10.1016/j.vaccine.2023.11.042. Epub 2023 Dec 7. Vaccine. 2024. PMID: 38061956 Free PMC article.
13 results